Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen | |||||
Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 98.34 |
Pershing Square Capital Management LP | 3.86 |
Pershing Square Holdings Ltd. | 3.45 |
T Rowe Price Mid Cap Growth Fund | 1.57 |
Pictet Asset Management Ltd. | 1.54 |
BlueSpruce Investments LP | 0.54 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 13'500 | 14'800 | 16'300 | 16'400 | 17'000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.33 | 0.33 | 0.32 | 0.33 | 0.37 |
Bilanz (in Mio. EUR) - Aktiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 4'169 | 3'848 | 3'189 | 3'415 | 3'799 |
Summe Anlagevermögen | 6'842 | 6'366 | 7'155 | 7'410 | 8'300 |
Summe Aktiva | 8'426 | 8'541 | 9'452 | 9'627 | 10'705 |
Bilanz (in Mio. EUR) - Passiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 2'011 | 1'799 | 2'407 | 2'537 | 2'911 |
Summe Fremdkapital | 3'591 | 3'970 | 4'704 | 4'754 | 5'316 |
Summe Eigenkapital | 4'835 | 4'571 | 4'748 | 4'873 | 5'389 |
Summe Passiva | 8'426 | 8'541 | 9'452 | 9'627 | 10'705 |
Adresse
5301 Stevens Creek Boulevard, 95051 Santa Clara | |
Telefon | +1 (800) 227-9770 |
URL | http://www.agilent.com |
Management
Allison Ballmer
Senior VP-Strategy & Corporate Development |
Boon Hwee Koh
Non-Executive Chairman |
Brian Carothers
Vice President & GM, Nucleic Acid Solutions |
Daniel K. Podolsky
Independent Director |
Darlene J. S. Solomon
Chief Technology Officer & Senior Vice President |
David Hwang
Managing Director-Early Stage Partnership |
Dominique P. Grau
Senior Vice President-HR & Global Communications |
Dow R. Wilson
Independent Director |
George A. Scangos
Independent Director |
Guillermo Gualino
Treasurer & Vice President |
Hans Edgar Bishop
Independent Director |
Heidi Kunz Fields
Independent Director |
Henrik Ancher-Jensen
SVP & President-Order Fulfillment & Supply Chain |
Jacob Thaysen
SVP & President-Life Sciences & Applied Markets |
Jenipher E. Dalton
Senior VP-Global Quality & Regulatory Affairs |
John Palma
Vice President-Medical Affairs |
Katharine Knobil
Chief Medical Officer |
Kristin Giffin
Vice President & GM-Services & Support Division |
Lonnie G. Justice
Chief Marketing & Customer Experience Officer |
Mala Anand
Independent Director |
Michael R. McMullen
President, Chief Executive Officer & Director |
Michael Tang
Secretary, Senior Vice President & General Counsel |
Mikael Dolsten
Independent Director |
Otis W. Brawley
Independent Director |
Padraig Mcdonnell
President-Agilent Cross Lab Group |
Robert W. McMahon
Chief Financial Officer & Senior Vice President |
Rodney Gonsalves
Chief Accounting Officer, VP & Controller |
Samraat S Raha
SVP & President-Diagnostic & Genomics Group |
Stephen Bonovich
Vice President-Global Taxation |
Sue H. Rataj
Independent Director |